This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Bio-Reference To License From University Of Washington

ELMWOOD PARK, N.J., July 22, 2013 /PRNewswire/ -- Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) ( announced today that it signed a licensing agreement with the University of Washington to transition, and all other related properties to become a business unit of Bio-Reference.

Since 1992, has been a key resource for physicians, geneticists and genetic counselors seeking comprehensive information about testing for inherited disorders and genetic counseling services.  In fact, receives about 22,000 visitors each business day.

" is highly regarded by everyone in the field," said vice president of marketing for Bio-Reference, Amar Kamath. "We recognized that has been providing a community service since molecular genetics was in its infancy, and we're pleased to be preserving and maintaining this valuable resource free-of-charge to users. It would have been a huge loss to the medical community to let it go." lists more than 600 international labs offering genetic testing for more than 3,000 disorders. In addition, provides information concerning over 1,100 international genetics clinics, which provide diagnostic and genetic counseling services to patients and their families.

Both directories are provided free of charge to the public and participating laboratories and clinics.

"As the field of genetics has grown more complex and specialized, has become one of the most indispensable tools of the trade as a single source of information on genetic test availability," said founder Roberta "Bonnie" Pagon, M.D., who is now a consultant to Bio-Reference and has assumed the role of Medical Director of "Initially, the lab directory was used primarily by geneticists, but today clinicians in all specialties, such as cardiology, endocrinology and neurology, rely on for easy-to-access, easy-to-understand information on tests for inherited disorders."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.61 -0.14%
FB $118.61 0.88%
GOOG $698.44 0.78%
YHOO $36.53 -0.19%
TSLA $241.99 0.51%


Chart of I:DJI
DOW 17,888.04 +114.40 0.64%
S&P 500 2,081.59 +16.29 0.79%
NASDAQ 4,818.61 +43.2520 0.91%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs